Detalhe da pesquisa
1.
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
N Engl J Med
; 385(17): 1547-1558, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670042
2.
Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects.
Antimicrob Agents Chemother
; 61(1)2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27799203
3.
Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects.
J Antimicrob Chemother
; 72(3): 820-828, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27999038
4.
Efficacy and safety of danoprevir-ritonavir plus peginterferon alfa-2a-ribavirin in hepatitis C virus genotype 1 prior null responders.
Antimicrob Agents Chemother
; 58(2): 1136-45, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24295986
5.
Antiviral activity of danoprevir (ITMN-191/RG7227) in combination with pegylated interferon α-2a and ribavirin in patients with hepatitis C.
J Infect Dis
; 204(4): 601-8, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21791662
6.
Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients.
J Hepatol
; 55(5): 972-9, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21354234
7.
Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: a phase 1b multiple ascending dose study.
J Hepatol
; 54(6): 1130-6, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21145848
8.
CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial.
Ann Rheum Dis
; 69(11): 2013-6, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20693270
9.
Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial.
Hum Vaccin Immunother
; 14(3): 596-608, 2018 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28968138
10.
Immunogenicity and safety of the Southern Hemisphere 2015 formulation of Vaxigrip®.
Hum Vaccin Immunother
; 13(11): 2674-2677, 2017 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28937844
11.
Safety and tolerability of high-dose formoterol (via Aerolizer) and salbutamol in patients with chronic obstructive pulmonary disease.
Respir Med
; 100(4): 666-72, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16303295
12.
Ritonavir-boosted danoprevir-based regimens in treatment-naive and prior null responders with HCV genotype 1 or 4 and compensated cirrhosis.
Hepatol Int
; 10(3): 478-87, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26886127
13.
A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial.
Vaccine
; 31(18): 2295-301, 2013 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23510665
14.
Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirin.
Antivir Ther
; 17(5): 927-32, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22611092
15.
Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy.
Antiviral Res
; 89(3): 238-45, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21255610
16.
Short-term administration of the CCR5 antagonist vicriviroc to patients with HIV and HCV coinfection is safe and tolerable.
J Acquir Immune Defic Syndr
; 53(1): 78-85, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19838130
17.
The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5.
AIDS
; 22(3): 430-2, 2008 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-18195571
18.
SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders.
Gastroenterology
; 132(4): 1270-8, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17408662